HEALTHEQUITY, INC. Selling and Marketing Expense in USD from 2012 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Healthequity, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2012 to Q2 2025.
  • Healthequity, Inc. Selling and Marketing Expense for the quarter ending July 31, 2025 was $19.9M, a 7.45% decline year-over-year.
  • Healthequity, Inc. Selling and Marketing Expense for the twelve months ending July 31, 2025 was $91.6M, a 7.5% increase year-over-year.
  • Healthequity, Inc. annual Selling and Marketing Expense for 2024 was $90.7M, a 14.5% increase from 2023.
  • Healthequity, Inc. annual Selling and Marketing Expense for 2023 was $79.3M, a 15.1% increase from 2022.
  • Healthequity, Inc. annual Selling and Marketing Expense for 2022 was $68.8M, a 17.5% increase from 2021.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

HEALTHEQUITY, INC. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $91.6M $19.9M -$1.6M -7.45% May 1, 2025 Jul 31, 2025 10-Q 2025-09-02
Q1 2025 $93.2M $26M +$2.49M +10.6% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-03
Q4 2024 $90.7M $23.1M +$2.53M +12.3% Nov 1, 2024 Jan 31, 2025 10-K 2025-03-18
Q3 2024 $88.2M $22.6M +$2.98M +15.2% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-09
Q2 2024 $85.2M $21.5M +$2.4M +12.6% May 1, 2024 Jul 31, 2024 10-Q 2025-09-02
Q1 2024 $82.8M $23.5M +$3.56M +17.9% Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-03
Q4 2023 $79.3M $20.6M +$1.36M +7.07% Nov 1, 2023 Jan 31, 2024 10-K 2025-03-18
Q3 2023 $77.9M $19.7M +$2.41M +14% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-09
Q2 2023 $75.5M $19.1M +$3.28M +20.7% May 1, 2023 Jul 31, 2023 10-Q 2024-09-03
Q1 2023 $72.2M $19.9M +$3.38M +20.4% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-03
Q4 2022 $68.8M $19.2M +$2.88M +17.7% Nov 1, 2022 Jan 31, 2023 10-K 2025-03-18
Q3 2022 $66M $17.2M +$4.52M +35.5% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-05
Q2 2022 $61.4M $15.8M +$367K +2.37% May 1, 2022 Jul 31, 2022 10-Q 2023-09-05
Q1 2022 $61.1M $16.6M +$2.47M +17.6% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-07
Q4 2021 $58.6M $16.3M +$2.86M +21.2% Nov 1, 2021 Jan 31, 2022 10-K 2024-03-22
Q3 2021 $55.8M $12.7M -$154K -1.2% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-08
Q2 2021 $55.9M $15.5M +$3.31M +27.2% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q1 2021 $52.6M $14.1M +$2.63M +23% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-08
Q4 2020 $50M $13.5M -$474K -3.4% Nov 1, 2020 Jan 31, 2021 10-K 2023-03-30
Q3 2020 $50.4M $12.9M +$226K +1.79% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-09
Q2 2020 $50.2M $12.2M +$3.78M +45% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q1 2020 $46.4M $11.5M +$2.49M +27.7% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-08
Q4 2019 $44M $13.9M +$6.04M +76.6% Nov 1, 2019 Jan 31, 2020 10-K 2022-03-31
Q3 2019 $37.9M $12.7M +$5.15M +68.7% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-09
Q2 2019 $32.8M $8.39M +$1.15M +15.9% May 1, 2019 Jul 31, 2019 10-Q 2020-09-09
Q1 2019 $31.6M $8.97M +$2.11M +30.8% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-04
Q4 2018 $29.5M $7.89M +$461K +6.2% Nov 1, 2018 Jan 31, 2019 10-K 2021-03-31
Q3 2018 $29M $7.5M +$1.61M +27.3% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-05
Q2 2018 $27.4M $7.24M +$2.05M +39.4% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 $25.4M $6.86M +$2.24M +48.5% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-06
Q4 2017 $23.1M $7.43M +$1.88M +33.8% Nov 1, 2017 Jan 31, 2018 10-K 2020-03-31
Q3 2017 $21.3M $5.89M +$1.5M +34.2% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-06
Q2 2017 $19.8M $5.19M +$1M +24% May 1, 2017 Jul 31, 2017 10-Q 2018-09-06
Q1 2017 $18.8M $4.62M +$438K +10.5% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
Q4 2016 $18.3M $5.56M +$891K +19.1% Nov 1, 2016 Jan 31, 2017 10-K 2019-03-28
Q3 2016 $17.4M $4.39M +$1.32M +43.2% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q2 2016 $16.1M $4.19M +$1.45M +53.1% May 1, 2016 Jul 31, 2016 10-Q 2017-09-07
Q1 2016 $14.7M $4.18M +$1.35M +47.7% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 $13.3M $4.67M +$875K +23.1% Nov 1, 2015 Jan 31, 2016 10-K 2018-03-28
Q3 2015 $12.4M $3.07M +$792K +34.8% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q2 2015 $11.6M $2.74M +$416K +17.9% May 1, 2015 Jul 31, 2015 10-Q 2016-09-08
Q1 2015 $11.2M $2.83M +$600K +26.9% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-09
Q4 2014 $10.6M $3.79M Nov 1, 2014 Jan 31, 2015 10-K 2017-03-30
Q3 2014 $2.28M +$399K +21.3% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-09
Q2 2014 $2.32M +$484K +26.3% May 1, 2014 Jul 31, 2014 10-Q 2015-09-10
Q1 2014 $2.23M Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-11
Q3 2013 $1.88M Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-11
Q2 2013 $1.84M May 1, 2013 Jul 31, 2013 10-Q 2014-09-12

HEALTHEQUITY, INC. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $90.7M +$11.5M +14.5% Feb 1, 2024 Jan 31, 2025 10-K 2025-03-18
2023 $79.3M +$10.4M +15.1% Feb 1, 2023 Jan 31, 2024 10-K 2025-03-18
2022 $68.8M +$10.2M +17.5% Feb 1, 2022 Jan 31, 2023 10-K 2025-03-18
2021 $58.6M +$8.64M +17.3% Feb 1, 2021 Jan 31, 2022 10-K 2024-03-22
2020 $50M +$6.01M +13.7% Feb 1, 2020 Jan 31, 2021 10-K 2023-03-30
2019 $44M +$14.5M +49% Feb 1, 2019 Jan 31, 2020 10-K 2022-03-31
2018 $29.5M +$6.36M +27.5% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $23.1M +$4.82M +26.3% Feb 1, 2017 Jan 31, 2018 10-K 2020-03-31
2016 $18.3M +$5.02M +37.7% Feb 1, 2016 Jan 31, 2017 10-K 2019-03-28
2015 $13.3M +$2.68M +25.3% Feb 1, 2015 Jan 31, 2016 10-K 2018-03-28
2014 $10.6M +$2.02M +23.4% Feb 1, 2014 Jan 31, 2015 10-K 2017-03-30
2013 $8.6M +$807K +10.4% Feb 1, 2013 Jan 31, 2014 10-K 2016-03-31
2012 $7.8M Feb 1, 2012 Jan 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.